COVID-19 vaccination among patients with cicatricial alopecia: patient concerns, experiences, and treatment modifications

• Kelly E. Flanagan, MS,
• James T. Pathoulas, BA,
• Maryanne M. Senna, MD,
• Chloe J. Walker, MD, MHS,
• Isabel Pupo Wiss, BA,
• Maya Collins, BS,
• Shaheir Ali, BA,
• Rita Wanser, MS,
• Jean Pickford, BS,
• Wilma Bergfeld, MD

Affiliations

Kelly E. Flanagan, MS

a Massachusetts General Hospital, Department of Dermatology, Boston, Massachusetts

James T. Pathoulas, BA

a Massachusetts General Hospital, Department of Dermatology, Boston, Massachusetts

Maryanne M. Senna, MD

a Massachusetts General Hospital, Department of Dermatology, Boston, Massachusetts

Chloe J. Walker, MD, MHS

a Massachusetts General Hospital, Department of Dermatology, Boston, Massachusetts

Isabel Pupo Wiss, BA

a Massachusetts General Hospital, Department of Dermatology, Boston, Massachusetts

Maya Collins, BS

a Massachusetts General Hospital, Department of Dermatology, Boston, Massachusetts

Shaheir Ali, BA

a Massachusetts General Hospital, Department of Dermatology, Boston, Massachusetts

Rita Wanser, MS

b Cicatrical Alopecia Research Foundation, Philadelphia, PA, USA

Jean Pickford, BS

b Cicatrical Alopecia Research Foundation, Philadelphia, PA, USA

Wilma Bergfeld, MD

c Cleveland Clinic, Department of Dermatology, Cleveland, Ohio